Resources for Small Business Awardees
NIA small business funding is more than money—it also provides access to data, animal models, laboratory testing support, and training in entrepreneurship and regulatory rules to help your organization be successful.
Technical and Business Assistance (TABA)
All applicants can request additional funding for technical and business services, such as access to technologies or support on product sales, intellectual property protections, market research, and planning. Requests should be made within the application under “F. Other Direct Costs, lines 8-10” and labeled “Technical and Business Assistance” on the budget.
- Phase I has a cap of $6,500 per year.
- Phase II has a cap of $50,000 for the life of the project.
Phase I applicants who request a budget allowance for technical assistance are not eligible to receive a TABA Needs Assessment Report (see below).
The TABA Needs Assessment Report provides a third-party, unbiased assessment of a Phase I awardee’s project progress in 10 technical and business areas that are critical to success in the competitive healthcare marketplace. In addition to suggesting the highest priority steps participants can take to improve the commercial potential of a product or service, the no-cost report provides a strong foundation for Phase II funding applications. TABA accepts applications throughout the year; reports are completed in just 2–3 months.
NIA strongly encourages all Phase I awardees to apply to TABA. Applicants seeking Phase II funding are encouraged to use findings from the TABA Needs Assessment Report during Phase I to inform technical assistance budget allowance requests in the Phase II application.
Phase I Awardees
Innovation Corps (I-Corps™) at NIH Program
This entrepreneurship immersion course is a hands-on, real-world training designed to turn scientists into entrepreneurs. Phase I awardee teams spend 8 weeks outside the lab, learning to succeed in business through intensive in-person and online courses, mentoring, networking and market research. Graduates are prepared to focus their business plans, reach their potential customers, and effectively demonstrate the value of their innovation. In addition to training, I-Corps provides up to $55,000 to cover direct program costs.
Phase II Awardees
Commercialization Readiness Pilot (CRP) Program
CRP provides technical assistance and later-stage research and development (R&D) support that is not typically provided under Phase II and Phase IIB awards. Budgets may not exceed $1,750,000 in total funding support in any year up to the funding opportunity award limit of $3,360,358 in total costs across all years. CRP applicants may apply for technical assistance or late-stage R&D support.
Funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, post-docs, and eligible investigators from groups that have been shown to be underrepresented in health-related research or in the SBIR/STTR programs. This supplement opportunity is also available to Program Directors/Principal Investigators of research grants who are or become disabled and need additional support to accommodate their disability to continue to work on the research project. Administrative supplements must support work within the scope of the original project.
This 24-week entrepreneurial training course is designed to provide medical device innovators with specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab to the market. Through this program, NIH fosters the development and commercialization of early-stage biomedical technologies by engaging investigators who are interested in better understanding the value of their innovation in addressing an unmet market need. The curriculum and customized mentoring are intended to guide investigators as they assess the commercial viability and potential business opportunity for their innovation.
Entrepreneur-In-Residence (EIR) Support
As an Entrepreneur-In-Residence for NIA, Diane Ignar, PhD, RPh, provides valuable guidance and entrepreneurial coaching to NIA-funded companies by sharing the knowledge and experience gained during her tenure at GlaxoSmithKline. She has worked in new technology development, preclinical drug discovery, clinical development, and business development. She has held senior leadership roles in life-science startups and has assisted numerous startups at Duke University and University of North Carolina with business strategy, R&D planning and seed funding. Diane holds four patents and has published 40 papers. Get in touch with Diane today!
Another Entrepreneur-In-Residence for NIA, John P. Reinhart, CPA, MBA, provides valuable guidance and entrepreneurial coaching to NIA-funded companies. John has extensive experience in longevity economy innovations and is a co-founder and board member of the Thrive Center in Louisville, Kentucky, a not-for-profit innovation center that brings together consumers, entrepreneurs, researchers, investors, providers, and distributors to explore solutions that enhance both the quality of life and care for a global aging population. He has held executive roles at several health care companies, including a multistate long-term care provider and an electronic health records software venture that was acquired by a NASDAQ company. Get in touch with John today!
NIH Small business Education and Entrepreneurial Development (SEED)
The SEED Innovator Support Team is a free business resource for small business awardees seeking assistance with commercializing their technology and ensuring success in the market. Support is provided on an as-needed basis to assist with your commercialization objectives. The team can provide:
- Pitch coaching
- Product and business strategy
- Business development and partnerships
- Investor networking
- Competitive analysis
- Deal review
- Regulatory and reimbursement planning
- General business advice
NIA makes the following data and animal model resources available to academic researchers and small businesses:
A knowledge platform for the dissemination of data and analysis to scientists working on preclinical therapy development for Alzheimer's disease (AD).
A multicenter consortium established by NIA to develop next-generation animal models for AD research.
Colonies of barrier-raised, Specific Pathogen-Free (SPF) rodents specifically for use in aging research, available to investigators at academic and nonprofit research institutions.
Return to the NIA Small Business Main Page.